Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. NVO
NVO logo

NVO

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

NVO News

Eli Lilly's Market Cap Surpasses $1 Trillion Again

19h agoYahoo Finance

CVS Restores Coverage for Eli Lilly's Weight Loss Drug

1d agostocktwits

Intense Pharmaceutical Rivalry: Novo Nordisk vs. Eli Lilly in GLP-1 Market

1d agoFool

Competitive Analysis of Novo Nordisk and Eli Lilly

1d agoNASDAQ.COM

France Becomes First EU Nation to Reimburse Weight Loss Medications

1d agoseekingalpha

CVS Restores Coverage for Eli Lilly's Weight Loss Drug Zepbound

1d agoCNBC

Truist Initiates Coverage on VKTX with Buy Rating and $83 Price Target

1d agostocktwits

Novo Nordisk and Eli Lilly Intensify Anti-Obesity Drug Competition

2d agoFool

Trump's Financial Disclosures Reveal Eli Lilly Transactions

2d agoFool

Jim Cramer Recommends Four Stocks for New Investors

2d agoCNBC

Signos Secures $20 Million Funding to Expand Market Presence

2d agoCNBC

Signos Secures $20 Million Funding and Expands Partnership with Dexcom

2d agoNewsfilter

Former Netflix CFO David Wells Buys HIMS Shares Amid Market Concerns

3d agostocktwits

Obesity Drug Market Poised for Growth

3d agoFool

Weight Loss Drug Market Poised for Growth

3d agoNASDAQ.COM

Eli Lilly Becomes First Healthcare Company to Reach $1 Trillion Market Cap

4d agostocktwits